hi BK14,
Thanks for the post the PDF was very informative and had some very interesting comments. looks like bene has had the injectible solution around for a while just been looking for the right partner to pony up and bring it to market.
Can u elaborate on your comment re the oral formulation with Celebrex in particular its ramifications to PAR.
I’m no patent attorney but recently Paul presented at a forum in which he said any oral formulation of IPPS is covered under PARs current patents.
thanks again
Poolboy
Its been done before., page-42
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.0¢ | 23.0¢ | $74.10K | 315.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3245 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 3703 | 1 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |